Walgreens Boots Alliance Inc (NASDAQ:WBA) has earned an average recommendation of “Buy” from the twenty-three research firms that are presently covering the company, MarketBeat reports. Ten equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $84.12.
Several brokerages have recently commented on WBA. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 target price for the company in a report on Wednesday. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Tuesday. ValuEngine downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Mizuho set a $87.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Finally, BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, January 10th.
In other news, insider Stefano Pessina bought 98,858 shares of the company’s stock in a transaction on Monday, January 15th. The shares were bought at an average cost of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 14.80% of the company’s stock.
Shares of Walgreens Boots Alliance (NASDAQ WBA) traded down $0.17 during midday trading on Wednesday, hitting $68.29. The stock had a trading volume of 6,791,500 shares, compared to its average volume of 5,978,584. Walgreens Boots Alliance has a twelve month low of $63.82 and a twelve month high of $88.00. The stock has a market capitalization of $67,850.00, a P/E ratio of 18.86, a price-to-earnings-growth ratio of 1.16 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. During the same period in the prior year, the business posted $1.10 earnings per share. Walgreens Boots Alliance’s revenue was up 7.9% compared to the same quarter last year. research analysts anticipate that Walgreens Boots Alliance will post 5.71 earnings per share for the current fiscal year.
Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.
The company also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.34%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
TRADEMARK VIOLATION NOTICE: This article was first reported by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2018/02/14/walgreens-boots-alliance-inc-wba-given-consensus-rating-of-buy-by-analysts.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.